Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 5
2013 5
2014 3
2015 5
2016 9
2017 3
2018 8
2019 17
2020 10
2021 18
2022 11
2023 12
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year

Filters applied: . Clear all
Page 1
Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer.
Turner NC, Oliveira M, Howell SJ, Dalenc F, Cortes J, Gomez Moreno HL, Hu X, Jhaveri K, Krivorotko P, Loibl S, Morales Murillo S, Okera M, Park YH, Sohn J, Toi M, Tokunaga E, Yousef S, Zhukova L, de Bruin EC, Grinsted L, Schiavon G, Foxley A, Rugo HS; CAPItello-291 Study Group. Turner NC, et al. N Engl J Med. 2023 Jun 1;388(22):2058-2070. doi: 10.1056/NEJMoa2214131. N Engl J Med. 2023. PMID: 37256976 Clinical Trial.
Response.
Péron J, You B. Péron J, et al. J Natl Cancer Inst. 2013 Feb 6;105(3):244-5. doi: 10.1093/jnci/djs511. J Natl Cancer Inst. 2013. PMID: 23520607 No abstract available.
Advances in the management of peritoneal malignancies.
Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O. Kepenekian V, et al. Among authors: peron j. Nat Rev Clin Oncol. 2022 Nov;19(11):698-718. doi: 10.1038/s41571-022-00675-5. Epub 2022 Sep 7. Nat Rev Clin Oncol. 2022. PMID: 36071285 Review.
Restricted Net Treatment Benefit in oncology.
Piffoux M, Ozenne B, De Backer M, Buyse M, Chiem JC, Péron J. Piffoux M, et al. Among authors: peron j. J Clin Epidemiol. 2024 Apr 1;170:111340. doi: 10.1016/j.jclinepi.2024.111340. Online ahead of print. J Clin Epidemiol. 2024. PMID: 38570079 Free article.
Survival and modelled cancer antigen-125 ELIMination rate constant K score in ovarian cancer patients in first-line before poly(ADP-ribose) polymerase inhibitor era: A Gynaecologic Cancer Intergroup meta-analysis.
Corbaux P, You B, Glasspool RM, Yanaihara N, Tinker AV, Lindemann K, Ray-Coquard IL, Mirza MR, Subtil F, Colomban O, Péron J, Karamouza E, McNeish I, Kelly C, Kagimura T, Welch S, Lewsley LA, Paoletti X, Cook A. Corbaux P, et al. Among authors: peron j. Eur J Cancer. 2023 Sep;191:112966. doi: 10.1016/j.ejca.2023.112966. Epub 2023 Jul 4. Eur J Cancer. 2023. PMID: 37542936 Free article.
96 results